Okay, let's tackle this question. The patient has glaucoma and is on acetazolamide. The lab results show a pH of 7.34, which is slightly acidic. The PCO2 is low at 29 mmHg, and HCO3- is 15 mEq/L. So, first, I need to figure out what kind of acid-base disorder this is.

Acetazolamide is a carbonic anhydrase inhibitor. I remember that carbonic anhydrase is involved in the production of bicarbonate in the kidneys. By inhibiting this enzyme, acetazolamide reduces bicarbonate reabsorption in the proximal tubule, leading to increased excretion of bicarbonate. That would cause a metabolic acidosis.

But wait, the patient has a low HCO3- (which fits with metabolic acidosis) and a low PCO2. In metabolic acidosis, the body compensates by hyperventilation to blow off CO2, which lowers PCO2. So the low PCO2 here is a respiratory compensation for the primary metabolic acidosis. The pH is 7.34, which is just below normal, so it's a compensated metabolic acidosis.

Now, the options aren't listed, but the correct answer should be metabolic acidosis with respiratory compensation. Let me think of the possible options. Common acid-base disorders include metabolic acidosis, metabolic alkalosis, respiratory acidosis, respiratory alkalosis. Since the pH is slightly low and HCO3- is low, the primary issue is metabolic acidosis. The low PCO2 is the body's way of compensating.

So the correct answer is metabolic acidosis with respiratory compensation. The other options would be incorrect because, for example, respiratory alkalosis would have a low PCO2 but normal or high HCO3- if chronic. Metabolic alkalosis would have high HCO3- and high PCO2. Acetazolamide's mechanism directly leads to bicarbonate loss, so the key here is understanding that the drug causes metabolic acidosis, and the body compensates by reducing CO2.

**Core Concept**
Acetazolamide, a carbonic anhydrase inhibitor, induces **metabolic acidosis** by blocking bicarbonate (HCO₃⁻) reabsorption in the proximal renal tubule. This leads to **bicarbonate wasting** in urine, lowering plasma HCO₃⁻. The body compensates for metabolic acidosis via **hyperventilation**, reducing PaCO₂.

**Why the Correct Answer is Right**
The patient’s lab values (pH 7.34, HCO₃⁻ 15 mEq/L, PaCO₂ 29 mmHg) indicate **compensated metabolic acidosis**. Acetazolamide inhibits carbonic anhydrase in renal tubules, impairing HCO₃⁻ reabsorption. This creates a **bicarbonate deficit**, lowering serum HCO₃⁻. The low PaCO₂ reflects **respiratory compensation** (hyperventilation) to expel CO₂ and partially correct pH.

**Why Each Wrong Option is Incorrect**
**Option A:** *Respiratory acidosis* is incorrect because PaCO₂ is decreased, not elevated.
**Option B:** *Metabolic alkal

✓ Correct Answer: A. Metabolic acidosis